ABSTRACT
The human leukocyte antigen (HLA) alleles are extremely polymorphic among ethnic population and the peptide binding specificity varies for different alleles in a combinatorial manner. However, it has been suggested that majority of alleles can be covered within few HLA supertypes, where different members of a supertype bind similar peptides, yet exhibiting distinct repertoires. Since the overlap between different members of a supertype appears to be extensive, it is crucial to develop a framework for grouping alleles into supertypes just from sequence information.
In this report, we define sub supertypes, where members show functional overlap with identical repertoire, and describe a strategy to group HLA-A, B and C alleles into different categories of sub supertypes. The strategy grouped 47% of 295 A alleles, 44% of 540 B alleles and 35% of 156 C alleles to just 36, 71 and 18 groups, respectively. The grouping is moderately validated using available binding data. However, the validation is limited due to lack of binding data. Hence, the data presented in this article serve as a framework to test specific functional overlap between alleles.
The grouping of HLA alleles into different categories of sub supertypes has profound use in the understanding of antigenic peptide selection, degeneration and discrimination during T-cell mediated immune response. A complete knowledge of this phenomenon finds utility in epitope design for the development of HLA based vaccines and immuno-therapeutics.
INTRODUCTION
The human leukocyte antigen (HLA) alleles are highly polymorphic among ethnic population. Today, more than 1,800 HLA alleles are known and about a 1,000 of them refer to the class I loci (1) . Class I alleles bind peptides of length 8-10 residues during T-cell mediated immune response (2) . Therefore, the huge combination of specific HLA-peptide binding is clearly beyond our realization. However, it has been suggested that a majority of alleles can be grouped within few "HLA supertypes", where the members of a supertype bind similar peptides, yet distinct binding repertoires (3) . The functional overlap between different alleles within defined supertypes will significantly reduce peptide binding diversity. A catalogue of functional overlap is critical for grouping alleles into supertypes from sequence information. In recent years, a number of supertypes have been defined by comparing peptide binding data. Thus, HLA-A1 (4), A2 (3, 5) , A3 (5), A24 (4), B7 (5), B27 (4), B44 (6), B58 (4), and B62 (4) supertypes have been defined. Classification of alleles into supertypes using binding data is seldom comprehensive and conclusive. Moreover, a complete grouping of all known alleles using binding data is laborious and expensive. It is also practically impossible to cluster all known alleles using binding data at multiple levels of functional overlaps. Therefore, it is critical to develop theoretical procedures for grouping alleles into supertypes. However, such grouping procedures require rigorous validation prior to routine application. Chelvanayagam (11) used clustering procedures for grouping HLA alleles into putative supertypes. In this report, we utilize the procedure described by Zhao et al. (9) to define HLA 'sub-supertypes' with overlapping function of identical binding repertoire. Using this approach, we grouped 991 alleles (class I) into several groups of 'sub-supertypes'. The grouping is further validated using binding data extracted from MHCBN (12) . The importance of HLA sub-supertypes in establishing a conclusive framework for functional overlaps between alleles is discussed.
MATERIALS AND METHOD

Dataset
The protein sequences of HLA-A (295 alleles), HLA-B (540 alleles) and HLA-C (156 alleles) were obtained from IMGT/HLA (release 2.5) for this analysis (1).
Structural basis for HLA supertypes
HLA allele sequences show high degree of homology among themselves. Therefore, their structures have similar fold and peptide binding groove, where the 3-dimensional spatial orientations of residue backbone atoms are similar for various alleles at different residue positions. However, HLA alleles exhibit extreme polymorphism among themselves and their peptide binding specificity varies between them. Nonetheless, the peptide binding residues show similarity among certain alleles and these alleles binding identical peptides through the concept of HLA supertypes (Table 1 ).
Definition of HLA sub-supertypes
In this approach, we define critical polymorphic functional residue positions (CPFRP) for each allele using a methodology described elsewhere (9) . Here, CPFRPs are described as those positions that are predominantly involved in peptide binding in known MHCp crystal structures and show polymorphism at least once among known A, B and C allele sequences. Thus, 21 CPFRPs were defined for each allele. The physical and chemical properties of residues at the CPFRPs characterize the binding difference between alleles. It has been shown that it is possible to sub-group members of a supertype using just 21 residues polymorphic in pockets A-F of the peptide binding groove (9) . Hence, the 21 CPFRP residues were extracted for HLA A, B and C alleles. The extracted discontinuous residue segment patterns formed by the CPFRPs were compared and alleles having identical CPFR segments were grouped together. Thus, alleles clustered within a group share identical CPFR segments and are proposed to form functional pockets capable of binding similar peptides with identical repertoire (Tables 2 -4) . Therefore, members of a group bind similar peptides and the groups represent "sub-supertypes". It is proposed that the "sub-supertypes" would have the predictive power previously promised for the supertype itself.
Validation of predictive sub-supertypes
The grouping is reasonably validated using binding data (Tables 5 -6 ) extracted from MHCBN (12) . Here, we show several peptides, found in the literature, that are bound by two members of the same sub-supertype. In this article, a total of five pairs of alleles in five subsupertypes (three of which are HLA-A, and two of which are HLA-B) are found to have similar peptide binding. It should be noted that the utility of this approach awaits more rigorous experimental validation.
RESULTS AND DISCUSSION
HLA Supertypes
More than 1,800 HLA alleles have been defined (1) . Therefore, the number of theoretically possible combinations of HLA-peptide complexes is extremely large. However, the immune system maintains a homogenous balance by specific selection, degeneration and discrimination (self/non-self) of short peptides using HLA molecules. Although, HLA molecules are polymorphic in ethnic population, they exhibit a substantial amount of functional overlap through the phenomenon of 'HLA supertypes', where members bind similar peptides and yet display distinct repertoires. A number of 'HLA supertypes' have already been defined using binding data (Table 1) . Table 1 shows six peptides binding to all members of the A2 supertypes (A*0201, A*0202, A*0203, A*0206 and A*6802). The functional overlap between different members of the supertype is intriguing. However, it also shows several peptides binding to some members but not all members of the A2 supertypes (Table 1) .
Perplexing issues with HLA supertypes
The concept of HLA supertypes is that alleles belonging to supertypes bind a highly shared set of peptides; in principle it should be possible to predict peptide binding of other members of a supertype using experimental results based on just one member of the type. However, as illustrated in Table I , this promise does not hold in the major supertypes A and B. Hence, the binding of peptides to different members of the A2 supertype is combinatorial in selection and degeneration. Moreover, this grouping is inconclusive given the known number of HLA alleles. Therefore, we devised a theoretical procedure to group HLA alleles into clusters of overlapping function from sequence information (9). 
Reduction of HLA sequence diversity
Our previous analysis grouped 101 HLA-A alleles into 29 clusters such that each group contains at least two alleles with identical functional binding CPFR segments (9) . In this report, we extended the grouping to HLA-A, -B and -C alleles. Here, we used 991 alleles (class I) of which, 295 are 'A alleles', 540 are 'B alleles' and 156 are 'C alleles'. The discontinuous CPFR residue segment patterns were extracted for each allele (9) . Comparison of these segment patterns among HLA-A, B and C alleles grouped A alleles into 192 unique clusters, B alleles into 373 unique clusters and C alleles into 119 unique clusters. Thus, 991 alleles were grouped into 684 clusters. The total diversity among the 991 alleles is reduced to 69% with a 'reduction in variability' of 31%. The diversity in A, B and C is reduced to 65%, 69% and 76%, respectively with a 'reduction in variability' of 35%, 31% and 24%, respectively. An understanding of such reduction among the functionally important binding residues is critical to decipher the molecular basis for HLA-supertypes.
HLA sub-supertypes
In this study, 139 A alleles (47% of all known A alleles) were clustered into 36 groups such that each group contains at least two alleles (Table 2) . Members in each of these groups have identical CPFR segment patterns. Thus, alleles within a group have identical functional pockets. The proposed hypothesis is that alleles in a group bind to similar peptides and members in the group form 'subupertypes' with identical binding repertoire. If binding of a peptide is known for one representative allele in a group, its binding to other members in the group can be deduced. However, this clustering has to be validated using experimentally determined binding data for a representative set of alleles. This requires large scale generation of binding data and it is difficult to generate binding data at such scale due to limitations in the synthesis and purification of HLA alleles for binding assay. If this hypothesis is reasonably validated using binding data, it is possible to infer the binding property of a peptide to 47% of A alleles using binding values for 36 representative A alleles. The 36 groups clustered A alleles into A1, A2, A3, A11, A23, A24, A26, A29, A30, A31, A32, A33, A34, A36, A66, A68 and A74 'predictive sub-supertypes' where members of a group is proposed to bind similar peptides ( Table 2) . We extended our analysis to B alleles and showed that 238 B alleles (44% of all known B alleles) were clustered into 71 groups such that each group contains at least two alleles (Table 3 ). We also show that 55 C alleles (35% of all known C alleles) were grouped into 18 groups such that each group contains at least two alleles (Table 4) . Thus, we demonstrate that the strategy (9) used to group alleles into subsupertypes is extremely powerful in reducing functional diversity.
Validation of predictive sub-supertypes
In order to validate the proposed hypothesis, we extracted peptides from MHCBN (12) . This experiment (Table 5 ). In Table 2 , A*0201 and A*0209 are categorized together (Group #2). Comparison of Table 5 with Table 2 suggest that peptides binding to A*0201, also binds to A*0209. This observation is very interesting. However, it is important to establish the binding of these peptides to other members of the group such as A*0224, A*0225, A*0231, A*0240, A*0243, A*0245, A*0246, A*0258, A*0259, A*0266, A*0267 and A*026. It should be noted that it is labor intensive to clone and express all of these alleles to determine binding to the above peptides. Nonetheless, if experimentally determined binding data show similar binding to all these alleles, then extrapolation of the proposed hypothesis to other predictive sub-supertype is trivial.
We found yet another peptide GILGFVFTL which binds to A*0206 and A*0214 (Table 5 ). These two alleles are categorized together in 'Group #4' ( Table 2 ). This observation is also interesting. However, if similar binding of this peptide to other members of 'Group 4' such as A*0221, A*0228, A*0251 and A*0261 is established, extrapolation of this strategy to other predictive sub-supertypes will be trivial (Table 2 ). Interestingly, GILGFVFTL binds A*0201, A*0209, A*0206 and A*0214 (Table 5) . Although, GILGFVFTL binds all the above four alleles, our strategy grouped these alleles into two distinct groups (Group #2 (A*0201 & A*0209) and Group #4 (A*0206 & A*0214)). We further probed into their functional overlap but examining their CPFR segments. Examination of CPFR segments in Group #2 and Group #4 (Table 2) shows a single residue mutation (9F to 9Y) between these two groups. F (phenylalanine) and Y (tyrosine) are aromatic and the mutation is synonymous. This explains binding overlap between members of Group #2 and Group #4. By definition, our strategy groups members with similar peptide binding and members across groups (for example, Group #2 and Group #4) do not always bind similar peptides. We also found that a number of peptides (LLFNILGGWV, YLVAYQATV, KVAELVHFL, FLWGPRALV, FLLLADARV, IMIGVLVGV) bind A*0201 (Group #2) and A*0206 (Group #4). A*0201 and A*0206 are grouped as members of A2 supertype using binding data ( Table 1 ). The data implies that some peptides binding to A*0201 are also found to bind A*0206. However, this is not always true. Peptides (WMNRLIAFA, ILHNGAYSL, YLSGANLNL, VMAGVGSPYV, ILAGYGAGV) that bind to A*0201 do not always bind to A*0206 (Table 1) . This suggests that A*0201 and A*0206 are not strict members of the A2 'sub-supertype'. On the other hand, we propose that peptides that bind to A*0201 should strictly bind to A*0209 as they share identical CPFR segments (Table 2) . Similarly, A*0206 and A*0214 should always bind similar peptides as they share identical CPFR segments ( Table 2 ).
The CPFR segments in A*0201 (Group 2) and A*0202 (Group 3) shows single residue mutation (156L to Table  2 .
156W). The residues leucine (L) and tryptophan (W) are hydrophobic and the mutation is synonymous. Therefore, some peptides that bind A*0201 are also found to bind A*0202 (Table 1 ). This trend is not always true (Table 1) . Therefore, A*0201 and A*0202 are not strict members of the A2 'sub-supertype'. In yet another case, the peptide RASGVDRYY binds A*3002 and A*3003 (Table 5 ). Table  2 shows that A*3002 and A*3003 are grouped together with another allele A*3012 (Group #22) and members of this group are proposed to bind similar peptides. Therefore, the binding of this peptide to A*3012 will be of great significance to validate this hypothesis. We further validated the grouping for B alleles using binding data for 2 pairs of alleles (B*2703/B*2705 and B*5101/B*5102) and the data is given in Table 6 . The pairs B*2703/B*2705 (Group #27) and B*5101/B*5102 (Group #56) strictly bind similar peptides (Tables 3 and 6 ). More than 20 peptides were shown to bind each of the allele pairs clustered in Group #27 and Group #56. However, the binding of other members of the group is required for further extrapolation.
Here, we demonstrate using binding data for 3 pairs of HLA-A alleles (A*0201/A*0209 (Group #2), A*0206/A*0214 (Group #4) and A*3002/A*3003 (Group #22) that alleles within a group (Table 2) bind similar peptides (Table 5 ). The validation is extended to two pairs of B alleles B*2703/B*2705 and B*5101/B*5102 (Table 3  and Table 6 ). Thus, our methodology groups alleles into strict supertypes, where members always bind similar peptides (Tables 2 and 5 ). We also note that there may be some degree of functional overlap (Table 6 ) across members of different groups (A*0201 (Group 2) / A*0206 (Group #4)) due to synonymous residue substitutions at the CPFRP (Table 2 ). Several peptide binders of A*0201 are non-binders to A*0206 (Table 1) . Hence, the functional overlap across groups (Table 1 and Table 2 ) is not always true. This warrants that grouping of HLA alleles into supertypes based on binding data is seldom conclusive and comprehensive ( Table 1 ). The validation of the grouping strategy is limited in the current report. Further validation is required to apply this methodology to group alleles into 'sub-supertypes' from sequence information on a large scale. It is our hope that the clustering provided here will serve as a theoretical framework for investigating the phenomenon of HLA supertypes using binding data.
CONCLUSIONS
Knowledge on all possible combinations of MHCp binding is useful in the design of peptide vaccine candidates, immuno-therapeutic targets and diagnostics agents. The theoretically possible combinations are overwhelmingly large. However, the functional overlap between alleles and the grouping of alleles into 'sub-supertypes' is extremely powerful in understanding peptide selection and degeneration. Grouping of alleles into supertypes using binding data is seldom conclusive and comprehensive. The strategy described in this report, grouped 47% of known A alleles (295), 44% of known B alleles (540) and 35% of known C alleles (156) to just 36, 71 and 18 groups,
